Correction: Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer.
BMC Cancer
; 24(1): 114, 2024 Jan 23.
Article
in En
| MEDLINE
| ID: mdl-38262962